Literature DB >> 11044082

Adeno-associated virus (AAV) Rep protein enhances the generation of a recombinant mini-adenovirus (Ad) utilizing an Ad/AAV hybrid virus.

Z Sandalon1, D V Gnatenko, W F Bahou, P Hearing.   

Abstract

Mini-adenoviruses (mAd) deleted of all viral coding regions represent an emerging approach for transgene expression. We have exploited the unique features of the adeno-associated virus (AAV) terminal repeats within the context of an adenovirus-adeno-associated hybrid virus (Ad/AAV) as a strategy for rapid and efficient generation of mAd. Excision and generation of mAd from the parental Ad/AAV hybrid vector was achieved in 293 cells through recombination but without selection for mAd production. Analysis of mAd isolated from 293 cells indicated that mAd DNA exists as monomer and dimer forms within the recombinant viral capsid. Formation of recombinant mAd was significantly increased using an AAV Rep78- or Rep68-expressing cell line through Rep-mediated excision utilizing the AAV terminal repeat sequences present in the Ad/AAV hybrid virus genome. The mAd viruses were infectious and able to transfer functional gene to A549 and HeLa cells. This approach is rapid and efficient, thereby providing a simplified methodology for generating mAd with functional transducing capabilities.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044082      PMCID: PMC110912          DOI: 10.1128/jvi.74.22.10381-10389.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.

Authors:  A Lieber; D S Steinwaerder; C A Carlson; M A Kay
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

Review 2.  High-capacity adenoviral vectors for gene transfer and somatic gene therapy.

Authors:  S Kochanek
Journal:  Hum Gene Ther       Date:  1999-10-10       Impact factor: 5.695

Review 3.  Use of adeno-associated virus as a general transduction vector for mammalian cells.

Authors:  N Muzyczka
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

4.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

5.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

6.  Palindromic adenovirus type 5-simian virus 40 hybrid.

Authors:  Y Gluzman; K Van Doren
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

7.  Mechanism of activation of early viral transcription by the adenovirus E1A gene product.

Authors:  J R Nevins
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

8.  Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome.

Authors:  P Hearing; R J Samulski; W L Wishart; T Shenk
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

9.  Packaging capacity and stability of human adenovirus type 5 vectors.

Authors:  A J Bett; L Prevec; F L Graham
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Cloning of a DNA fragment from the left-hand terminus of the adenovirus type 2 genome and its use in site-directed mutagenesis.

Authors:  N D Stow
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

View more
  4 in total

1.  Computationally designed adeno-associated virus (AAV) Rep 78 is efficiently maintained within an adenovirus vector.

Authors:  Varsha Sitaraman; Patrick Hearing; Charles B Ward; Dmitri V Gnatenko; Eckard Wimmer; Steffen Mueller; Steven Skiena; Wadie F Bahou
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

2.  A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.

Authors:  Dmitry M Shayakhmetov; Cheryl A Carlson; Hartmut Stecher; Qiliang Li; George Stamatoyannopoulos; André Lieber
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Altering the Ad5 packaging domain affects the maturation of the Ad particles.

Authors:  Raul Alba; Dan Cots; Philomena Ostapchuk; Assumpcio Bosch; Patrick Hearing; Miguel Chillon
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

4.  Viral hybrid vectors for somatic integration - are they the better solution?

Authors:  Nadine Müther; Nadja Noske; Anja Ehrhardt
Journal:  Viruses       Date:  2009-12-15       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.